Divestitures, Currency Translation Lead to 17 Percent Q1 Revenue Decline for Bruker | GenomeWeb

NEW YORK (GenomeWeb) – Bruker reported after the close of the market Wednesday that its first quarter revenues fell around 17 percent, largely due to divestitures, the negative effect of currency translation, and weak sales for its nuclear magnetic resonance business.

Bruker reported total revenues of $353.5 million for the three months ended March 31, down from $423.7 million for the first quarter of 2014 and below analysts' consensus estimate of $369.8 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.